Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I). [electronic resource]
Producer: 20130329Description: 90-101 p. digitalISSN:- 1541-2563
- Administration, Inhalation
- Adult
- Aged
- Double-Blind Method
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Intention to Treat Analysis
- Male
- Middle Aged
- Muscarinic Antagonists -- administration & dosage
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Quality of Life
- Spirometry
- Surveys and Questionnaires
- Treatment Outcome
- Tropanes -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.